ʻO Hong Kong lāua ʻo Phnom Penh, Cambodia, Iune 22, 2021/PRNewswire/ – Ua ʻae ke Kuhina Ola ʻo Cambodia i ke kālepa ʻana o ka INDICAID® COVID-19 rapid antigen test ma ke ʻano he ʻāpana o ka hoʻoikaika ʻana o ka ʻāina e kāohi i ka piʻi ʻana o COVID-19. hihia .
Ua hoʻonoho ke aupuni Cambodia i nā hoʻokolohua antigen wikiwiki e like me INDICAID® e hana i ka nānā nui ʻana ma ke kapikala ʻo Phnom Penh a me nā wahi e pili ana, me ka hoʻohana ʻana i ka manawa pōkole a me ka maʻalahi o nā hopena hōʻike e kōkua i ke aupuni e ʻike koke i nā maʻi maʻi COVID-19 a pale i ka laha o ka mai.Ua alakaʻi ʻia kēia mau hoʻāʻo i nā hana hoʻopaʻa ʻoi aku ka maikaʻi, e hoʻokaʻawale maikaʻi i ke kapikala i nā wahi ʻulaʻula, ʻalani, a melemele e pili ana i ka nui o nā hihia a me ka hopena o ka hoʻouna ʻana.Hiki ke kūʻai ʻia aku ʻo INDICAID® ma Phnom Penh.
Ua ʻōlelo ʻo Ricky Chiu, ka mea nāna i hoʻokumu a me ka Luna Hoʻokele o PHASE Scientific: "Ke manaʻoʻiʻo nei mākou ʻo ka pololei, ka maʻalahi o ka hoʻohana ʻana a me ka loaʻa ʻana o kā mākou pahu hoʻāʻo e hana ai ʻo INDICAID® i mea koʻikoʻi i ka hana screening i hana ʻia e ke aupuni Cambodia ma ka ʻāina.kuleana.”Mea hana mana o ka pahu ho'āʻo INDICAID®."Hoʻokipa mākou i ka hoʻoholo a ke aupuni Cambodia a ke kakali nei mākou i ka hoʻohana ʻana i kā mākou pahu hoʻāʻo wikiwiki e kākoʻo i kona mau ʻāina kokoke."
Ua ʻōlelo ʻo Chiu he nui nā ʻāina i hoʻohana i ka INDICAID® e hakakā i ka COVID-19.Ma Hong Kong kahi i hoʻokumu ʻia ai ka PHASE Scientific, ua ʻike ʻia ʻo INDICAID® e ke aupuni ma ke ʻano he huahana i koho ʻia no nā kipa hale maʻi a me nā kahu hānai.ʻO ia ka hōʻailona kūʻai maikaʻi loa ma waena o nā huahana like a ua kūʻai aku ma mua o 2 miliona mau pahu.Hoʻohana nui ʻia ia e nā haukapila, aupuni a me nā hui pilikino, nā hale kūʻai, nā hōkele a me nā kula no ka nānā ʻana maʻamau a me ka honua.
ʻO INDICAID® COVID-19 Rapid Antigen Test he immunoassay lateral flow i hoʻopaʻa ʻia i ka CE i hoʻolālā ʻia e ʻike pono i ka antigen SARS-CoV-2 i nā laʻana swab nasal.Me ka maikaʻi o ka huahana hilinaʻi a me ka maʻalahi o ka hoʻohana ʻana, hiki i ka INDICAID® ke hāʻawi koke i nā hopena i loko o 20 mau minuke, me ka ʻole o ka pono o nā mea hana kūikawā.Ua hōʻoia ʻia ka pololei o kēia pahu hoʻāʻo i loko o ka hoʻokolohua lapaʻau ʻelua-alanui nui loa o ka honua, kahi i hoʻāʻo ʻia ai ʻo INDICAID® e kūʻē i ka PCR ma mua o 9,200 mau laʻana a hōʻike i ka ʻike kiʻekiʻe a me ka kikoʻī.
Loaʻa ka INDICAID® i kēia manawa ma 33 mau ʻāina a ke kaʻina nei e loaʻa kahi mana hoʻohana pilikia (EUA) mai ka US Food and Drug Administration (FDA).
Mea kākau: John Vandermosten, CFA TSX: PMN.TO |OTC: ARFXF |NASDAQ: BIIB ʻO kekahi o nā kaʻa kaʻa hauʻoli loa i ke kahua biotechnology ʻo ia ka moʻolelo aducanumab i hana ʻia i nā makahiki i hala.ʻO Aducanumab, me ka mea kūʻai aku ʻo Aduhelm, he amyloid-directed monoclonal antibody no ka mālama ʻana i ka maʻi o Alzheimer (AD).Hoʻopaʻa ʻo Aduhelm i ke ʻano aggregate o amyloid a loaʻa
Ua pūlima ka hui kūʻokoʻa ʻo Cantex Pharmaceuticals Inc i kahi ʻaelike laikini me vTv Therapeutics Inc (NASDAQ: VTVT) e hoʻomohala a kūʻai aku i ka azeliragon o vTv.Wahi a nā ʻōlelo o ka ʻaelike, ʻo Cantex ke kuleana no ka hoʻomohala ʻana a me ka hoʻolaha ʻana o azeliragon, a na nā hui ʻelua e puʻunaue i nā waiwai ma lalo o kahi hoʻonohonoho hierarchical.ʻAʻole i hōʻike ʻia nā kikoʻī kālā ʻē aʻe."No laila, aia kahi manawa e hoʻomohala ai i ka azeliragon, kahi hoʻokele lāʻau oral phase 2
Hoʻokomo ka ʻoihana ʻohana mau i nā kumu kūleʻa nui ʻehā e hāpai i ka hui ʻana o ka ʻohana, ka ulu ʻana o ka ʻoihana a me ka mālama waiwai lōʻihi.
Mea kākau: Kauka David Bautz Nasdaq: MNOV Heluhelu i ka hōʻike noiʻi MNOV piha ʻO ka hoʻolaha pāʻoihana MN-166 Phase 2 nā hopena maikaʻi o ka Australian dollar trial June 21, 2021, MediciNova, Inc. (NASDAQ: MNOV ) Ke hoʻolaha nei i nā hopena maikaʻi o ka Phase 2 Ua paʻi ʻia ka hoʻokolokolo ʻana o MN-166 (Ibudilast) i ka Alcohol Use Disorders (AUD) ma ka Nature publication Translational Psychiatry (Grodin et al., 2021).ʻO ka hoʻokolokolo a
Ua ʻae ka honua i nā lāʻau lapaʻau influenza me ka maikaʻi ʻaʻole ʻoi aku ma mua o 50%, no laila hiki i nā huahana maikaʻi ke hoʻololi hou i ka mākeke a hoʻonui paha i ka mākeke.
(Bloomberg)-Ke ʻimi nei nā luna olakino o New Zealand e ʻimi i nā pilina o kahi huakaʻi Australia mai Sydney i kipa aku iā Wellington i ka hopena pule a ua maʻi pū ʻia me Covid-19.I ka ʻike ʻana o kēia neʻe ʻana e hiki ai i nā mea hoʻonohonoho ʻOlumepika Tokyo ke haʻalele i ka hoʻolālā e kūʻai aku i ka waiʻona ma nā wahi, ua hōʻike ʻo Kyodo News ua kōkua ia i ka hoʻolaha ʻana o ka maʻi, akā ʻaʻohe ona kuleana.Ke hopohopo nei nā luna e pili ana i ka hiki ʻana mai o nā ʻano hou, hoʻolālā ʻo Kina e mālama i nā palena huakaʻi no ka liʻiliʻi o kekahi makahiki.ʻAe ka Hale Keʻokeʻo
E komo i nā pae hou o ke ola 10, e hoʻomanaʻo e kau i ka wāwae ma luna o ka pale noʻonoʻo no kāu mau hoʻolālā.www.vhis.gov.hk E nānā!
Ma hope o ka puka ʻana o ka coronavirus a puni ke kula, ʻōlelo ʻo ʻIseraʻela i ka hoʻopaʻa ʻana i ka poʻe ʻōpio, ʻo ka poʻe i hoʻopaʻa piha ʻia hiki ke loaʻa i ka maʻi maʻi no ka mea ke hoʻopiʻi nei nā luna i ka ʻano like ʻole o ka Delta.Ua hōʻike ka ʻāina i 125 mau hihia hou i 24 mau hola i ka Pōʻalua, ʻo ka helu kiʻekiʻe loa o ka lā hoʻokahi mai ka hopena o ʻApelila.Ma hope o ka hoʻāʻo ʻana, ua ʻike ʻia ka laha hou loa ma kekahi mau kula, a ma hope o ka hoʻokiʻekiʻe ʻana o ka ʻIseraʻela i nā mea paʻa coronavirus
Ua make ke kaikamahine a kahi limahana kalana ʻaʻole i hoʻopaʻa ʻia ma Florida ma hope o ka COVID-19 i kāʻili ʻia ma ka hale keʻena aupuni kahi āna i hana ai.Ua ʻōlelo ʻo ia ua hōʻole ʻole ʻo ia a me kona ʻohana i ka lāʻau lapaʻau, ʻoiai ʻaʻole maʻi iki ka hoa hana o ko lākou makuahine i hoʻopaʻa ʻia.ʻAʻohe mea o koʻu ʻohana i kano, "i ʻōlelo ai ʻo Molly Hart i ka Daily Beast.Ua make ka makuahine o Hart, ʻo Mary Knight, 58, i nā pilikia pili i ka COVID-19 i ka pule i hala, Manatee County Identity Verification
Ma ka haʻawina Phase 2/3 i alakaʻi ʻia e ke Kula Nui o ka Lapaʻau o ke Kulanui o Wakinekona, ʻaʻole i hoʻomaikaʻi nā anti-amyloid antibodies o Eli Lilly and Company (NYSE: LLY) a me Roche Holdings (OTC: RHHBY) i ka hoʻomaikaʻi ʻana i nā Al Symptoms of Zheimer's disease (AD). ).makahiki.I kēia manawa, ʻōlelo ka poʻe noiʻi ua loaʻa iā lākou nā hōʻike e hiki i ka gantenerumab ʻo Roche ke kōkua i kekahi mau maʻi.Ma waena o ka poʻe i komo i ka hoʻokolokolo ma Dominant Alzheimer's Disease (DIAD), Roche's
No.1 micro-plan discount: 5 mau koho kumu kūʻai haʻahaʻa [$0 a i $75000], me ka ʻinikua lapaʻau o ka hui e hoʻopau i ka ʻinikua e hauʻoli i ka pale makahiki o 30 miliona.
ʻO Jewish General Hospital (JGH) he lālā lālā o ka Montreal Midwestern Health Service (CIUSSS) a ʻo ia ka mea mua e hui pū me Auger Groupe Conseil Inc. (AGC) a me Medtronic Canada ULC (kahi hui o Medtronic (NYSE: MDT)) E hoʻohana iā Microsoft HoloLens no ka manawa maoli, ka lōʻihi o ka ʻoiaʻiʻo (XR) kākoʻo lapaʻau no ka hōʻoki ʻana i ka puʻuwai liʻiliʻi.
Ua hui pū ʻo Dr. Susannah Hills, he Kauka Pediatric Airway Surgeon a me ke Kauka Kokua o Otolaryngology ma Columbia University Medical Center, i hui pū me Yahoo Finance e kūkākūkā i nā nūhou hou e pili ana i ka maʻi maʻi coronavirus.
I ka nānā ʻana o ka poʻe noiʻi i ka hana mariuana o kahi hui o ka poʻe ma waena o 18 a me 30 mau makahiki, ua ʻike hou ʻia he 25 mau makahiki ma mua o ka noe.
ʻO nā kiʻi i hāʻawi ʻia e Pixaby Biotechnology ke kumu o kekahi o nā mea lapaʻau koʻikoʻi i ʻike ʻia ma ka honua i nā makahiki i hala.ʻO ka hapa nui o nā holomua holomua, e komo pū ana me nā kano COVID-19, ka ʻenehana nānā ʻana i ka maʻi maʻi, a me nā biobanks virtual, ua hele mai mai nā hoʻomaka a me nā ʻoihana liʻiliʻi.Aia he mau kaukani o ia mau mea hoʻomaka i ke kahua biotechnology.ʻO kā lākou ʻuhane paionia a me ka hoʻololi wikiwiki ʻana i kēia mau ʻoihana i kahi kūlana alakaʻi i ka ʻoihana biomedical.Eia kekahi
Ua hoʻohiki ʻo Mongolia i kona poʻe he "kauwela me ka Covid-19".Ua ʻōlelo ʻo Bahrain e "hoʻi i ke ola maʻamau."Ke manaʻo nei ka lāhui mokupuni liʻiliʻi o Seychelles e hoʻomaka i kāna ʻoihana.Ke manaʻoʻiʻo nei nā mea ʻekolu i ka liʻiliʻi loa i nā lāʻau lapaʻau maʻalahi i hana ʻia ma Kina, kahi e hiki ai iā lākou ke hoʻomaka i nā papahana hoʻopaʻapaʻa nui inā ʻaʻole lākou i loaʻa i ka hapa nui o ka honua.Eia nō naʻe, ke hakakā nei nā ʻāina ʻekolu i ka piʻi ʻana o nā maʻi ma mua o ka hoʻopau ʻana i ka coronavirus.kakauinoa
Ua hoʻolaha ʻo UniQure NV (NASDAQ: QURE) i ka ʻikepili 52-wiki o etranacogene dezaparvovec no ka mālama ʻana i ka hemophilia B i kāna hana 3 HOPE-B gene therapy hoʻāʻo.Hōʻike nā ʻikepili he 52 mau pule ma hope o ka mālama ʻana i ka hemophilia B, hoʻomau ka hana o ka mea IX (FIX) i hoʻonui.I loko o ka 26-week follow-up, ʻo ka awelika FIX hana i hoʻokomo ʻia ʻo 41.5% o ka waiwai maʻamau, a ʻo ka awelika FIX hana ʻo 39% o ka waiwai maʻamau.ʻO FIX kahi protein i hana maoli ʻia i loko o ke kino, e kōkua ana i ke koko e hana i kahi clot e hoʻōki i ke koko.I loko o kēia mau pule he 52, hoʻokahi
"Nūhou maikaʻi: maikaʻi kā kā mākou kano i nā ʻano like ʻole Delta," hoʻohui ʻo Fauci."Ke hōʻike nei kēia ʻano ʻokoʻa i kahi hoʻonohonoho o nā mutations e alakaʻi i nā mutations e haʻalele i kā mākou kano i ka wā e hiki mai ana.ʻO ia ke kumu i ʻoi aku ka maikaʻi o nā lāʻau lapaʻau ma mua o ka wā ma mua.ʻOi aku ka nui o ka manawa i mea e hoʻōki ai i ke kaulahao o ka maʻi - ke kaulahao o nā mutations e hiki ke alakaʻi i nā mutation ʻoi aku ka pōʻino, "wahi a Rochelle Walensky, ka luna o nā Centers for Disease Control and Prevention (CDC).ʻO ka ʻano Delta ka mea i hōʻeha ʻia i ka maʻi maʻi COVID-19 ma India i ʻApelila a me Mei, e hoʻomāhuahua ana i nā lawelawe olakino o ka ʻāina a ua make nā haneli he mau tausani.
Ua hōʻike ka hui biotechnology Kelemania ʻo BioNTech SE (BNTX) i kāna hoʻāʻo ʻana i ka Phase II o ka maʻi kanesa BNT111 no ka melanoma kiʻekiʻe, ua lawelawe ʻia ka mea maʻi mua i ka lāʻau.He paionia ʻo BioNTech i ka immunotherapy no ka maʻi kanesa, nā maʻi ʻeha a me nā maʻi maʻi ʻē aʻe.Loaʻa i ka hui kahi kōpili ākea o nā moho lapaʻau maʻi tumora, nā lāʻau lapaʻau hoʻololi protein, immunomodulators liʻiliʻi, nā antibodies hou a me nā lāʻau lapaʻau cell.ʻO ka lua o ka hoʻokolokolo ke aʻo ʻana i ka pono o ka admin BNT111
Ua ʻike ʻia kahi noiʻi hou i paʻi ʻia ma JAMA he 45 mau kāne i loaʻa i ka maʻi COVID-19 mRNA ʻaʻohe ʻokoʻa i nā ʻāpana sperm.ʻElua mau lāʻau lapaʻau mRNA i hoʻomohala ʻia e Pfizer a me Moderna ka mea maʻamau i hoʻohana ʻia i nā kano COVID-19 ma United States.Ua ʻōlelo ka poʻe noiʻi ma ke Kula Lapaʻau ʻo Miller ma ke Kulanui o Miami ua hoʻomaka lākou i ke aʻo ʻana ma hope o ka lohe ʻana i nā hopohopo o kekahi poʻe..Manaʻo ʻia hiki ke hoʻopōʻino i ka momona.Ua hōʻike lākou he mau palena kēia haʻawina
Ua hana ʻo Atai Life Science (NASDAQ: ATAI) i kāna hoʻomaka ma NASDAQ ma ka Pōʻalima.E hui pū ka hui ma Berlin i ka hui hoʻomaka kūʻokoʻa i ka ʻoihana psychedelic a e helu ʻia ma NASDAQ i kēia makahiki, me MindMed (NASDAQ: MNMD) a me Compass Pathways (NASDAQ) Code: CMPS).Me ke kākoʻo o Peter Thiel, ka mea nāna i hoʻokumu i PayPal (NASDAQ: PYPL), ua hoʻonui ka hui ma mua o $ 362 miliona ma ke kālā mai kona hoʻokumuʻiaʻana i ka makahiki 2018. Ua hoʻonuiʻo Atai i $ 225 miliona i kāna hāʻawi mua i ka Poaha.
Ua haʻi ʻo Kauka Ron Friedman, he kanaka psychologist a me ka mea kākau o ka puke "Decoding the Great," i haʻi aku iā Yahoo Finance Live ʻo nā hoʻololi i lawe ʻia e ka maʻi maʻi COVID-19 e hoʻomaka i kahi "hoʻololi i ke ʻano o ka hana ʻana o nā hui."
Ka manawa hoʻouna: Iune-23-2021